Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3724 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.32 USD | +0.47% | -5.26% | +18.03% | +96.36% | 176.80 M USD | ||
| 3736 |  PYXS Pyxis Oncology, Inc. - Common Stock | 2.76 USD | -10.10% | -4.83% | +64.29% | +144.25% | 174.86 M USD | ||
| 3739 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 9.43 USD | +0.53% | +4.31% | +24.74% | -43.19% | 174.72 M USD | ||
| 3745 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.84 USD | -3.16% | -0.54% | +4.55% | +5.14% | 172.44 M USD | ||
| 3750 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 1.62 USD | -2.41% | -7.95% | +4.52% | -28.00% | 170.68 M USD | ||
| 3756 |  HUMA Humacyte, Inc. - Common Stock | 0.76 USD | -1.30% | +5.56% | -44.93% | -70.99% | 168.73 M USD | ||
| 3760 |  ADCT ADC Therapeutics SA Common Shares | 1.32 USD | -3.65% | +17.86% | +34.69% | -55.56% | 167.89 M USD | ||
| 3767 |  MOLN Molecular Partners AG - American Depositary Shares | 4.09 USD | +0.74% | +5.14% | +11.44% | +13.61% | 165.13 M USD | ||
| 3791 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 4.41 USD | +2.56% | -6.96% | +15.75% | +320.00% | 158.83 M USD | ||
| 3802 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.25 USD | -3.10% | -8.09% | +0.81% | -44.93% | 155.62 M USD | ||
| 3808 |  IFRX InflaRx N.V. - Common Stock | 2.13 USD | +0.47% | -11.62% | +22.41% | +147.67% | 153.98 M USD | ||
| 3816 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.26 USD | 0.00% | -0.79% | +4.13% | -14.29% | 151.84 M USD | ||
| 3833 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 4.00 USD | -3.85% | +2.30% | -7.83% | +124.72% | 144.92 M USD | ||
| 3834 |  UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.42 USD | -0.18% | +11.07% | -19.94% | -16.74% | 144.71 M USD | ||
| 3838 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 2.27 USD | +2.71% | -4.62% | +1.79% | +94.02% | 142.93 M USD | ||
| 3843 |  YDES YD Bio Limited - Ordinary Shares | 2.00 USD | 0.00% | -11.50% | -32.20% | -75.00% | 141.58 M USD | ||
| 3846 |  HURA TuHURA Biosciences, Inc. - Common Stock | 2.21 USD | -1.34% | -13.33% | +7.80% | -10.89% | 140.74 M USD | ||
| 3847 |  PEPG PepGen Inc. - Common Stock | 2.02 USD | -1.46% | +14.77% | +50.75% | +75.65% | 139.72 M USD | ||
| 3859 |  SPRB Spruce Biosciences, Inc. - Common Stock | 49.95 USD | -1.62% | -3.52% | -1.52% | +354.09% | 137.48 M USD | ||
| 3861 |  CUE Cue Biopharma, Inc. - Common Stock | 33.88 USD | +1.47% | +15.71% | +15.36% | +4478.38% | 137.07 M USD |
Noticias Biotechnology Stocks
TD Cowen reitera su recomendación de compra en Prime Medicine tras ganar arbitraje
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |